Luye Pharma Submits New Drug Application in the U.S. for Its Antidepressant Drug LY03005

[In The News]

SHANGHAI, Dec. 26, 2019 /PRNewswire/ -- Luye Pharma Group has announced submission of a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for LY03005, a new chemical drug for the treatment of major depressive disorder. It is also the second U.S. FDA NDA submission...

View the full article